Data gathered: November 8
Alternative Data for Voyager Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 91 | Sign up | Sign up | Sign up |
| Webpage traffic | 8,000 | Sign up | Sign up | Sign up |
| Employee Rating | 64 | Sign up | Sign up | Sign up |
| Google Trends | 34 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,813 | Sign up | Sign up | Sign up |
| Twitter Followers | 954 | Sign up | Sign up | Sign up |
| Twitter Mentions | 26 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 54 | Sign up | Sign up | Sign up |
| Linkedin Employees | 203 | Sign up | Sign up | Sign up |
About Voyager Therapeutics
Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases.
| Price | $7.12 |
| Target Price | Sign up |
| Volume | 87,300 |
| Market Cap | $397M |
| Year Range | $5.77 - $10.54 |
| Dividend Yield | 0% |
| PE Ratio | 26.96 |
| Analyst Rating | 88% buy |
| Earnings Date | November 12 '24 |
| Industry | Biotechnology |
In the news
Voyager Therapeutics to Present at Multiple Upcoming Investor ConferencesNovember 6 - GlobeNewswire |
|
Voyager Therapeutics Announces Third Quarter 2024 Conference Call and WebcastNovember 5 - GlobeNewswire |
|
 |
Voyager Therapeutics (NASDAQ:VYGR) Upgraded at StockNews.comNovember 4 - ETF Daily News |
 |
Allspring Global Investments Holdings LLC Has $186,000 Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR)November 4 - ETF Daily News |
Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Takeda Pharmaceutical Company (TAK) and Voyager Therapeutics (VYGR)October 31 - TipRanks |
|
Analysts Offer Insights on Healthcare Companies: Merus (MRUS), IQVIA Holdings (IQV) and Voyager Therapeutics (VYGR)October 31 - TipRanks |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 30M | 10M | 19M | -10M | -14M | -0.180 |
| Q1 '24 | 20M | 8.6M | 11M | -11M | -15M | -0.200 |
| Q4 '23 | 90M | 10M | 80M | 56M | 55M | 1.250 |
| Q3 '23 | 4.6M | 8.3M | -3.6M | -26M | -29M | -0.590 |
| Q2 '23 | 4.9M | 8.3M | -3.4M | -22M | -24M | -0.510 |
Insider Transactions View All
| Fahey Sandell Jacquelyn filed to sell 86,001 shares at $5.8. October 3 '24 |
| Swartz Robin filed to sell 117,004 shares at $9.9. April 3 '24 |
| Sandrock Alfred filed to sell 322,839 shares at $9.9. April 3 '24 |
| Carter Todd Alfred filed to sell 87,627 shares at $7.5. February 22 '24 |
| PFREUNDSCHUH PETER P. filed to sell 175,669 shares at $7.5. February 22 '24 |
Similar companies
Read more about Voyager Therapeutics (VYGR) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Voyager Therapeutics?
The Market Cap of Voyager Therapeutics is $397M.
What is Voyager Therapeutics' PE Ratio?
As of today, Voyager Therapeutics' PE (Price to Earnings) ratio is 26.96.
When does Voyager Therapeutics report earnings?
Voyager Therapeutics will report its next earnings on November 12 '24.
What is the current stock price of Voyager Therapeutics?
Currently, the price of one share of Voyager Therapeutics stock is $7.12.
How can I analyze the VYGR stock price chart for investment decisions?
The VYGR stock price chart above provides a comprehensive visual representation of Voyager Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Voyager Therapeutics shares. Our platform offers an up-to-date VYGR stock price chart, along with technical data analysis and alternative data insights.
Does VYGR offer dividends to its shareholders?
As of our latest update, Voyager Therapeutics (VYGR) does not offer dividends to its shareholders. Investors interested in Voyager Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Voyager Therapeutics?
Some of the similar stocks of Voyager Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.